Investigational Site Number US294 — Lafayette, Louisiana

Investigational Site Number US294 is a clinical research site located in Lafayette, Louisiana, United States 70508.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Investigational Site Number US294 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: COVID-19, SARS-CoV-2 Infection.

Sponsors: Sanofi.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site Number US294?

Investigational Site Number US294 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site Number US294 conducted?

Investigational Site Number US294 has 1 clinical trials on record, with 1 currently active. Their work covers COVID-19, SARS-CoV-2 Infection.

Is Investigational Site Number US294 accredited by Crixeo Health?

Investigational Site Number US294 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site Number US294?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.